Confirming prior findings in other cancer models, DCN also suppresses tumor growth and invasion in IBC models by inhibiting the EGFR/ERK pathway25,58, and that it interacts physically with E-cadherin as previously shown in a colorectal cell line43. The gene discussed is EGFR; the disease is inflammatory breast carcinoma.